Risk of type 2 diabetes mellitus in polycystic ovary syndrome is associated with obesity: a meta-analysis of observational studies

[1] Mahler RJ(1999)Clinical review 102: type 2 diabetes mellitus: update on diagnosis, pathophysiology, and treatment J Clin. Endocrinol. Metab. 84 1165-1171

[2] Adler ML(2018)Polycystic ovarian syndrome (PCOS): long-term metabolic consequences Metabolism 86 33-43

[3] Anagnostis P(2018)Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome Hum. Reprod. 33 1602-1618

[4] Tarlatzis BC(2001)Age-related differences in features associated with polycystic ovary syndrome in normogonadotrophic oligo-amenorrhoeic infertile women of reproductive years Eur. J. Endocrinol. 145 749-755

[5] Kauffman RP(2020)Insulin resistance, androgens, and lipids are gradually improved in an age-dependent manner in lean women with polycystic ovary syndrome: insights from a large Caucasian cohort Hormones 19 531-539

[6] Teede HJ(2000)Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group JAMA 283 2008-2012

[7] Misso ML(2006)Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up Curr. Diab. Rep. 6 77-83

[8] Costello MF(2017)Metabolic concomitants of obese and nonobese women with features of polycystic ovarian syndrome J. Endocr. Soc. 1 1417-1427

[9] Dokras A(2014)Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study Fertil. Steril. 101 1123-1128

[10] Laven J(2000)Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome Hum. Reprod. 15 785-789

[1] Mahler RJ(1999)Clinical review 102: type 2 diabetes mellitus: update on diagnosis, pathophysiology, and treatment J Clin. Endocrinol. Metab. 84 1165-1171

[2] Adler ML(2018)Polycystic ovarian syndrome (PCOS): long-term metabolic consequences Metabolism 86 33-43

[3] Anagnostis P(2018)Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome Hum. Reprod. 33 1602-1618

[4] Tarlatzis BC(2001)Age-related differences in features associated with polycystic ovary syndrome in normogonadotrophic oligo-amenorrhoeic infertile women of reproductive years Eur. J. Endocrinol. 145 749-755

[5] Kauffman RP(2020)Insulin resistance, androgens, and lipids are gradually improved in an age-dependent manner in lean women with polycystic ovary syndrome: insights from a large Caucasian cohort Hormones 19 531-539

[6] Teede HJ(2000)Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group JAMA 283 2008-2012

[7] Misso ML(2006)Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up Curr. Diab. Rep. 6 77-83

[8] Costello MF(2017)Metabolic concomitants of obese and nonobese women with features of polycystic ovarian syndrome J. Endocr. Soc. 1 1417-1427

[9] Dokras A(2014)Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study Fertil. Steril. 101 1123-1128

[10] Laven J(2000)Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome Hum. Reprod. 15 785-789